References
- Scott P JW. Anticoagulant drugs in the elderly: the risks usually outweigh the benefits. Br Med J 1988; 297: 1261–1263
- Salzmann E W, Deykin D, Mayer Shapiro R, Rosenberg R. Management of heparin therapy. Controlled prospective trial. N Engl J Med 1975; 292: 1046–1050
- Wilcox C M, Truss C D. Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy. Am J Med 1988; 84: 683–690
- Whittle B JR, Kauffman G L, Moncada S. Hemostatic mechanism, independent of platelet aggregation, arrest gastric mucosal bleeding. Proc Natl Acad Sci 1986; 83: 5683–5687
- Salzman E W. Low molecular weight heparin. Is small beautiful. N Engl J Med 1986; 315: 957–959
- Hirsh J, Ofosu F A, Levine M. The development of low molecular weight heparins for clinical use. Thrombosis and hamostasis, M Verstraete, J Vermylen, H R. Lijnen, J Arout. Leuven University Press, LeuvenBelgium 1987; 325–345
- Cade J F, Buchanan M R, Boneu B. A comparison of the antithrombotic and haemorrhagic effect of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res 1984; 35: 613–625
- Mersereau W A, Hinchey E J. Effect of gastric acidity on gastric ulceration induced by hemorrhage in the rat utilizing a gastric chamber technique. Gastroenterology 1973; 64: 1130–1135
- Berstad A, Almodovar K, Berstad K, Anderson W. Effect of tranexamic acid on gastric bleeding in rats. Scand J Gastroenterol 1988; 23: 402–406
- Fernandez F, N'guyen P, Van Ryn J, Ofosu F A, Hirsh J, Buchanan M R. Haemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thromb Res 1986; 43: 491–495
- Arnesen H, Engebretsen L F, Ugland O M, Seljeflot I, Kierulf P. Increased fibrinolytic activity after surgery induced by low dose heparin. Thromb Res 1987; 45: 553–559
- Barrowcliffe T W, Merton R E, Gray E, Thomas D P. Heparin and bleeding: an association with lipase release. Thromb Haemost 1988; 60: 434–436